COVID-19 has had a calamitous effect on the global community. Despite intense study, the
immunologic response to the infection is only partially understood. In addition to older age …

Background As of November 2020, severe acute respiratory syndrome coronavirus 2 has
resulted in 55 million infections worldwide and more than 1.3 million deaths from …

Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …

A better understanding of COVID-19 in people with primary immunodeficiency (PI), rare
inherited defects in the immune system, is important for protecting this population, especially …

Primary antibody deficiencies, such as common variable immunodeficiency (CVID), are
heterogenous disease entities consisting of primary hypogammaglobulinemia and impaired …

Primary immunodeficiencies (PIDs) are heterogeneous, rare disorders that increase
susceptibility to infection and/or immune dysregulation. Individuals with certain PIDs are at …

COVID-19 in complex common variable immunodeficiency patient... : Current Opinion in Allergy
and Clinical Immunology COVID-19 in complex common variable immunodeficiency patients …

The clinical impact of coronavirus disease 2019 in primary immunodeficiency diseases
varies from mild illness to death. In our center, humoral immunodeficiency patients with poor …

Background Patients with some types of immunodeficiency can experience chronic or
relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Coronavirus disease 2019 (COVID-19) has spread rapidly and become a pandemic.
Caused by a novel human coronavirus called severe acute respiratory syndrome …